A Phase I Dose-Escalation Study of LY3405105, a Covalent Inhibitor of Cyclin-Dependent Kinase 7, Administered to Patients With Advanced Solid Tumors
LY3405105（一种细胞周期蛋白依赖性激酶 7 的共价抑制剂）治疗晚期实体瘤患者的 I 期剂量递增研究
期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyad215
Garralda, Elena; Schram, Alison M; Bedard, Philippe L; Schwartz, Gary K; Yuen, Eunice; McNeely, Samuel C; Ribeiro, Silvia; Cunningham, Jason; Wang, Yi; Urunuela, Arantxa; Xu, Xiaojian; LoRusso, Patricia
